1. Home
  2. ACRS vs CMCL Comparison

ACRS vs CMCL Comparison

Compare ACRS & CMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.33

Market Cap

529.9M

Sector

Health Care

ML Signal

HOLD

Logo Caledonia Mining Corporation Plc

CMCL

Caledonia Mining Corporation Plc

SELL

Current Price

$23.67

Market Cap

452.1M

ML Signal

SELL

Company Overview

Basic Information
Metric
ACRS
CMCL
Founded
2012
1992
Country
United States
Jersey
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
529.9M
452.1M
IPO Year
2015
2003

Fundamental Metrics

Financial Performance
Metric
ACRS
CMCL
Price
$3.33
$23.67
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$10.18
★ $43.88
AVG Volume (30 Days)
★ 3.5M
198.4K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
★ 2.36%
EPS Growth
★ 69.01
N/A
EPS
N/A
★ N/A
Revenue
★ $1,683,000.00
N/A
Revenue This Year
N/A
$24.19
Revenue Next Year
N/A
$6.55
P/E Ratio
★ N/A
$10.88
Revenue Growth
N/A
N/A
52 Week Low
$1.93
$15.85
52 Week High
$6.60
$36.35

Technical Indicators

Market Signals
Indicator
ACRS
CMCL
Relative Strength Index (RSI) 28.14 45.84
Support Level $3.16 $22.24
Resistance Level $3.44 $24.84
Average True Range (ATR) 0.33 0.88
MACD -0.08 -0.08
Stochastic Oscillator 6.31 36.45

Price Performance

Historical Comparison
ACRS
CMCL

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

About CMCL Caledonia Mining Corporation Plc

Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. Its project includes Maligreen and Motapa.

Share on Social Networks: